B Cell Maturation Antigen (BCMA) BINDING PROTEINS
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/EP2012/059762, filed May 24, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,466,893 | Antigen Binding Proteins In force · Medium confidence UsedRemaining | Glaxo Group Limited | In force | Medium confidence | ||
| US 11,419,945 | Antigen Binding Proteins In force · Medium confidence | Glaxo Group Limited | In force | Medium confidence | ||
| US 9,273,141 | B Cell Maturation Antigen (BCMA) BINDING PROTEINS In force · Medium confidence | Glaxo Group Limited | In force | Medium confidence | ||
| Application 14/122,391 | Bcma (CD269/TNFRSF17) - Binding Proteins Abandoned Abandoned May 16, 2016 | Glaxo Group Limited | Abandoned | Abandoned May 16, 2016 | ||
| Application 14/974,675 | Antigen Binding Proteins Abandoned Abandoned Nov 5, 2018 | Glaxo Group Limited | Abandoned | Abandoned Nov 5, 2018 | ||
| Application 15/828,770 | Antigen Binding Proteins Abandoned Abandoned Aug 17, 2020 | Glaxo Group Limited | Abandoned | Abandoned Aug 17, 2020 | ||
| Application 19/357,306 | Antigen Binding Proteins Pending Not granted | Glaxo Group Limited | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Glaxo Group Limited.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.